Skip to content

Dr. Pieter Luyten

Active Private limited companyfounded 2012active for 14 yearsHerembodegemstraat 75, 8552 ZwevegemKBO/BCE: BE 0849.074.256

Lifetime

13 annual accounts with figures on one time axis
peak of €667,403 in 2024
€640,875▼ 4.0%
peak of €500,233 in 2021
€441,394▼ 5.7%
peak of €1.1m in 2020
€120,900▼ 79.5%
€718,970▲ 139%
peak of 1.1 FTE in 2018
-not published
Board1 name since 2012
1 director
Documentsfilings and deeds
30-01-20261 day before the deadline
2025micro format
Dividend €909,553Equity from €589,059 to €120,900Debts from €301,411 to €718,970Cash from €275,691 to €387,663

Key points

from the 2025 annual accounts

Equity

€120,900 from €1.1m in 2020

Equity fell by 89% in 5 years.

Turnover

≈ €960,000 estimated

The accounts state no turnover.

Debts

€718,970 86% of the balance sheet
Suppliers 0%Taxes and wages 1%Other 99%

Of this, €582,325 falls due within a year.

Liquidity

1.20 was 4.68 in 2024

Short-term debts rose from €162,878 to €582,325.

Filings

13 annual accounts since 2013
deadline201520202025

The last five annual accounts were filed 1 to 43 days before the end of the period.

Position in the sector

€441,394

Higher net result than 95% of companies in human health. The sector median is €59,541, over 21,360 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,609 companies had the same profile as Dr. Pieter Luyten has now. Each dot stands for 7 companies, two years later.

96.8%
were still trading
2.1%
stopped another way
1.0%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,609 companies, not a prediction for Dr. Pieter Luyten. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 04-09-2012
  • founderdeed of 08-10-2012
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0849074256
changes role from manager to director Discharge granted to · General meeting of 09-03-2022 · Gazette deed
Registered office moved from Sint denijs - Zwevegem to Zwevegem - Moen The registered office moved from Ter Klare 7 te 8554 Sint denijs - Zwevegem to Herembodegemstraat 75 te 8552 Zwevegem - Moen · General meeting of 05-07-2018 · Gazette deed
Capital increase of €102,300 to €120,900 The capital rose from €18,600 to €120,900, with 1,023 new shares · General meeting of 01-06-2018 · Gazette deed
All 28 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Pieter Luyten Zwevegem €839,870 €640,875 14.4% -
CLARIS MEDICAL La Hulpe €860,642 €664,228 3.3% 8.3
DR. HANS CLAES Brasschaat €883,188 €589,874 91.0% -
Dokters DE MUYNCK-ZUTTERMAN Bruges €895,057 €577,168 48.7% -
Dr. Michiel Bonny en Dr. Veronique Buyse Dentergem €946,036 €503,972 38.2% -
DR. KRISTOF VERMEERSCH FYSISCHE GENEESKUNDE Kuurne €930,124 €783,759 60.6% -
Bruspor Bruges €777,194 €646,787 84.8% -

These companies have the same main activity as Dr. Pieter Luyten: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €777,000 and €946,000, founded between 2012 and 2016.

Official details

Source: KBO
Status
Active since 04-09-2012Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.213.079.0518554 Zwevegem, since 11-09-2012
Financial year end
30 June
Peppol
Reachable since 04-12-2025
Company details

Annual accounts to 30-06-2025

€839,870▼ 5.7%
Filing
Filed on 30-01-2026, 1 day before the end of the filing period
Financials

Insights on Dr. Pieter Luyten

Dr. Pieter Luyten files the micro format. That format states no turnover. The gross margin rose from €259,997 in 2013 to €640,875 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Pieter Luyten

What is the company number of Dr. Pieter Luyten?
The company number of Dr. Pieter Luyten is 0849.074.256. The VAT number is the same number with BE in front: BE 0849.074.256.
Where is Dr. Pieter Luyten based?
The registered office is at Herembodegemstraat 75, 8552 Zwevegem.Company details
What does Dr. Pieter Luyten do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Pieter Luyten?
Dr. Pieter Luyten is a private limited company (BV).
When was Dr. Pieter Luyten founded?
Dr. Pieter Luyten was founded on 04-09-2012.
Is Dr. Pieter Luyten still active?
Yes, Dr. Pieter Luyten is an active enterprise in the KBO register.
How many employees does Dr. Pieter Luyten have?
Dr. Pieter Luyten had an average of 0.1 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
What is the turnover of Dr. Pieter Luyten?
The turnover in financial year 2025 is about €960,000. This figure is estimated from the gross margin of €640,875 and 31 comparable companies (NACE 86220). It probably lies between €850,000 and €1.3m.
Is Dr. Pieter Luyten profitable?
In financial year 2025, Dr. Pieter Luyten made a profit of €441,394.
Where can I find the annual accounts of Dr. Pieter Luyten?
Dr. Pieter Luyten filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Pieter Luyten due?
Dr. Pieter Luyten must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.